Evaluation of radiation-induced oral mucositis by optical coherence tomography

Clinical Cancer Research

Volumn 11, Issue 14, 2005, Pages 5121-5127

  Muanza, Thierry M ^a,c   Cotrim, Ana P ^b   McAuliffe, Mathew ^d   Sowers, Anastasia L ^a   Baum, Bruce J ^b   Cook, John A ^a   Feldchtein, Felix ^e   Amazeen, Paul ^e   Coleman, C Norman ^a   Mitchell, James B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e Imalux Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOLONIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMAGE ANALYSIS; MOUSE; MOUTH CAVITY; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RADIATION INJURY; STOMATITIS;

EID: 22344440036     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0403     Document Type: Article

References (35)

1. Forastiere AA, Trotti A. Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional control and survival in oropharyngeal cancer. J Natl Cancer Inst 1999;91:2065-6.
2. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48:7-16.
3. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998;16: 1310-7.
4. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003;66:253-62.
5. Epstein JB, Schubert MM. Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management. Oncology (Huntingt) 2003;17: 1767-79.
6. Scully C, Epstein J, Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis. Head Neck 2004; 26:77-84.
7. Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 1998;34: 39-43.
8. Scully C, Epstein J, Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part1, pathogenesis and prophylaxis of mucositis. Head Neck 2003;25: 1057-70.
9. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-81.
10. Fujimoto JG, Brezinski ME, Tearney GJ, et al. Optical biopsy and imaging using optical coherence tomography. Nat Med 1995;1:970-2.
11. Tearney GJ, Brezinski ME, Southern JF, Bouma BE, Boppart SA, Fujimoto JG. Optical biopsy in human gastrointestinal tissue using optical coherence tomography. Am J Gastroenterol 1997;92: 1800-4.
12. Tearney GJ, Brezinski ME, Bouma BE, et al. In vivo endoscopic optical biopsy with optical coherence tomography. Science 1997;276:2037-9.
13. Sergeev AM, Gelikonov VM, Gelikonov GV, et al. In vivo endoscopic OCT imaging of precancer and cancer states of human mucosa. Optics Express 1997; 1:432-40.
14. Pitris C, Jesser C, Boppart SA, Stamper D, Brezinski ME, Fujimoto JG. Feasibility of optical coherence tomography for high-resolution imaging of human gastrointestinal tract malignancies. J Gastroenterol 2000;35:87-92.
15. Schuman JS, Puliafito CA, Fujimoto JG. Optical coherence tomography of ocular diseases. New Jersey: Slack Inc.; 2004.
16. Li Q, Timmers AM, Hunter K, et al. Noninvasive imaging by optical coherence tomography to monitor retinal degeneration in the mouse. Invest Ophthalmol Vis Sci 2001;42:2981-9.
17. Lambert R. Diagnosis of esophagogastric tumors. Endoscopy 2002;34:129-38.
18. Colston BW, Everett MJ, DaSilva LB, Otis LL, Stroeve P, Nathel H. Imaging of hard- and soft-tissue structure in the oral cavity by optical coherence tomography. Appl Opt 1998;37:3582-5.
19. Feldchtein FI, Gelikonov GV, Gelikonov VM, et al. In vivo OCT imaging of hard and soft tissue of the oral cavity. Optics Express 1998;3:239-50.
20. Clark AL, Gillenwater A, Alizadeh-Naderi R, El-Naggar AK, Richards-Kortum R. Detection and diagnosis of oral neoplasia with an optical coherence microscope. J Biomed Opt 2004;9:1271-80.
21. Wilder-Smith P, Jung WG, Brenner M, et al. In vivo optical coherence tomography for the diagnosis of oral malignancy. Lasers Surg Med 2004; 35:269-75.
22. Gladkova ND, Shakhov AV, Feldchtein FI. Capabilities of optical coherence tomography in laryngology. In: Bouma BE, Tearney GJ, editors. Handbook of optical coherence tomography. New York: Marcel Dekker, Inc.; 2002. p. 705-24.
23. McAuliffe MJ, Lalonde FM, McGarry D, Gandler W, Csaky K, Trus BL. Medical image processing, analysis, and visualization in clinical research. IEEE Trans Med Imaging 2001;381-6.
24. Otsu N. A threshold selection method from gray level histograms. IEEE Trans Systems Miin Cybernetics 1979;9:62-6.
25. Kujan O, Gleny AM, Duxbury J, Thakker N, Sloan P. Evaluation of screening strategies for improving oral cancer mortality: a cochrane systematic review. J Dent Educ 2005;69:255-65.
26. Dursun M, Yilmaz S, Yukselen V, Kilinc N, Canorue F, Tuzeu A. Evaluation of optimal gastric mucosal biopsy site and number for identification of Helicobacter pylori, gastric atrophy and intestinal metaplasia. Hepatogastroenterology 2004;60:1732-5.
27. Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura N. Helicobacter pylori infection, glandular atropy, and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer, and early gastric cancer. World J Gastroenterol 2005; 11:791-6.
28. Cooper JS, Quo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-7.
29. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340:1144-53.
30. Peters WAr, Liu PY, Barrett RJn, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18:1606-13.
31. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapyand Gastrointestinal Cooperative Groups. J Clin Oncol 1997;15:2040-9.
32. Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 1999;17: 2692-9.
33. Shen B, Zuccaro G, Gramlich TL, et al. Ex vivo histology-correlated optical coherence tomography in the detection of transmural inflammation in Crohn's disease. Clin Gastroenterol Hepatol 2004;2: 754-60.
34. Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE. Macular edema. Surv Ophthalmol 2004;49:470-90.
35. MacNeill BD, Jang IK, Bouma BE, et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol 2004;44:972-9.